與「"author:Miorin L"」相符的使用者個人學術檔案
![]() | Lisa MiorinResearch Assistant Professor, Icahn School of Medicine at Mount Sinai 在 mssm.edu 的電子郵件地址已通過驗證 被引用 14552 次 |
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
A newly described coronavirus named severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), which is the causative agent of coronavirus disease 2019 (COVID-19), has …
(SARS-CoV-2), which is the causative agent of coronavirus disease 2019 (COVID-19), has …
A serological assay to detect SARS-CoV-2 seroconversion in humans
Here, we describe a serological enzyme-linked immunosorbent assay for the screening and
identification of human SARS-CoV-2 seroconverters. This assay does not require the …
identification of human SARS-CoV-2 seroconverters. This assay does not require the …
SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of
the ongoing coronavirus disease 2019 (COVID-19) pandemic that is a serious global health …
the ongoing coronavirus disease 2019 (COVID-19) pandemic that is a serious global health …
Antagonism of type I interferon by flaviviruses
The prompt and tightly controlled induction of type I interferon is a central event of the
immune defense against viral infection. Flaviviruses comprise a large family of arthropod …
immune defense against viral infection. Flaviviruses comprise a large family of arthropod …
[HTML][HTML] The global phosphorylation landscape of SARS-CoV-2 infection
M Bouhaddou, D Memon, B Meyer, KM White… - Cell, 2020 - cell.com
The causative agent of the coronavirus disease 2019 (COVID-19) pandemic, severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has infected millions and killed …
respiratory syndrome coronavirus 2 (SARS-CoV-2), has infected millions and killed …
Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 2019
has triggered an ongoing global pandemic of the severe pneumonia-like disease …
has triggered an ongoing global pandemic of the severe pneumonia-like disease …
Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms
INTRODUCTION The emergence of three lethal coronaviruses in< 20 years and the urgency
of the COVID-19 pandemic have prompted efforts to develop new therapeutic strategies …
of the COVID-19 pandemic have prompted efforts to develop new therapeutic strategies …
Identification of a Universal Group B Streptococcus Vaccine by Multiple Genome Screen
D Maione, I Margarit, CD Rinaudo, V Masignani… - Science, 2005 - science.org
Group B Streptococcus (GBS) is a multiserotype bacterial pathogen representing a major
cause of life-threatening infections in newborns. To develop a broadly protective vaccine, we …
cause of life-threatening infections in newborns. To develop a broadly protective vaccine, we …
[HTML][HTML] MDA5 governs the innate immune response to SARS-CoV-2 in lung epithelial cells
Recent studies have profiled the innate immune signatures in patients infected with severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and suggest that cellular …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and suggest that cellular …
Zika virus targets human STAT2 to inhibit type I interferon signaling
The ongoing epidemic of Zika virus (ZIKV) illustrates the importance of flaviviruses as
emerging human pathogens. All vector-borne flaviviruses studied thus far have to overcome …
emerging human pathogens. All vector-borne flaviviruses studied thus far have to overcome …